Skip to content

Addiction: all studies

Page 289 of 860: studies 2,881 to 2,890 of 8,594, newest first. Back to the addiction overview

Research

Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.

Neuropsychopharmacology June 1, 2025 Johannes G. Ramaekers, Johannes T. Reckweg, Natasha L. Mason et al. 8 citations

3-Methylmethcathinone (3-MMC) is a designer drug that belongs to the group of synthetic cathinones. The compound has been scheduled in many jurisdictions because of public health concerns associated with excessive use. To date, there are no clinical studies that have evaluated the risk profile of 3-MMC in the recreational range of low to moderate doses. The current, first-in-human study (N =...

Neurotransmitter-related functional connectivity changes in serotonin and dopamine systems after mindfulness in medication overuse headache.

Cephalalgia June 1, 2025 Davide Fedeli, Giuseppe Ciullo, Greta Demichelis et al. 7 citations

Background/HypothesisMindfulness practice has gained attention in managing chronic migraine with medication overuse headache (CM-MOH), showing clinical improvements and functional connectivity reorganization. However, the relationship between these effects and the underlying neurotransmitter systems remains unexplored.MethodsThirty-four CM-MOH patients were divided into treatment as usual (TaU,...

Enduring modulation of dorsal raphe nuclei regulates (R,S)-ketamine-mediated resilient stress-coping behavior.

Molecular Psychiatry June 1, 2025 Anderson Camargo, Anna Nilsson, Reza Shariatgorji et al. 5 citations

Ketamine may be a novel pharmacologic approach to enhance resilience and protect against stress-related disorders, but the molecular targets underlying this response remain to be fully characterized. The multifunctional protein p11 is crucial in the pathophysiology of depression and antidepressant responses. However, it is still unclear whether p11 plays a role in the pro-resilience effects...

DOI: 10.1038/s41380-024-02853-6 (opens in new tab) Full text (opens in new tab) Mental health Psychopharmacology Stress resilience Ketamine therapy

Neural Electrical Correlates of Subjective Happiness.

Human Brain Mapping June 1, 2025 Wataru Sato, Takanori Kochiyama, Shota Uono 1 citation

Happiness is a subjective experience that can serve as the ultimate goal for humans. A recent study that employed resting-state functional magnetic resonance imaging (fMRI) reported that spontaneous fluctuation (fractional amplitude of low-frequency fluctuation: fALFF) in the precuneus is negatively associated with subjective happiness. However, little is known about the neural electrical...

DOI: 10.1002/hbm.70224 (opens in new tab) Full text (opens in new tab) Consciousness studies Subjective happiness scale Gamma‐band oscillation Precuneus +4

Advances in the study of NMDA receptors in depression pathogenesis and the antidepressant efficacy of their antagonists.

Asian Journal of Psychiatry June 1, 2025 Mingrui Chen, Jingyan Jin, Hongsheng Bi et al. 12 citations

N-methyl-D-aspartate receptors (NMDA receptors) play a crucial role as ionotropic glutamate receptors in regulating neuroplasticity, learning, memory, and a range of psychiatric disorders. Studies indicate that dysfunction of NMDA receptors is a key pathological mechanism in depression, where abnormal activation can result in neuronal excitotoxicity, excessive extracellular calcium ion...

DOI: 10.1016/j.ajp.2025.104502 (opens in new tab) Full text (opens in new tab) Antidepressants Glutamatergic Nmda receptor antagonists Nmda receptors +4

Psilocybin increases emotional empathy in patients with major depression.

Molecular Psychiatry June 1, 2025 Johannes Jungwirth, Robin von Rotz, Isabel Dziobek et al. 19 citations

Empathy plays a crucial role in interpersonal relationships and mental health. It is decreased in a variety of psychiatric disorders including major depression. Psilocybin, a promising candidate for treating depression, has been shown to acutely increase emotional empathy in healthy volunteers. However, no study has investigated this effect and its relevance for symptom improvement in a...

DOI: 10.1038/s41380-024-02875-0 (opens in new tab) Full text (opens in new tab) Mental health treatment Depression research Social connection Psilocybin therapy +1

Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.

Psychopharmacology June 1, 2025 Parsa Yousefi, Morten P. Lietz, Fiachra O'Higgins et al. 7 citations

Psilocybin shows promise for treating neuropsychiatric disorders. However, insight into its acute effects on cognition is lacking. Given the significant role of executive functions in daily life and treatment efficacy, it is crucial to evaluate how psilocybin influences these cognitive domains. This meta-analysis aims to quantify the acute effects of psilocybin on executive functions and...

DOI: 10.1007/s00213-024-06742-2 (opens in new tab) Full text (opens in new tab) Psilocybin effects Psychedelic research Mental processing Accuracy +8

A commentary on “What is it like to be a tetrachromat?” by Michael Newall

Philosophy and the Mind Sciences May 31, 2025 Jordi Galiano-Landeira

Analytical examinations of subjective experience are hampered by the first-person limitation described by Nagel (1974) in “What is it like to be a bat?”. This comment compares two examinations on the nature of subjective experience: Michael Newall’s (2025) analysis of tetrachromatic colour perception and Jordi Galiano-Landeira and Núria Peñuelas’ (2025) exploration of AI phenomenological...

Addressing the Global Challenge of Nitrous Oxide Misuse Through a Multidisciplinary Approach: Example of the PROTOSIDE Network

Toxics May 31, 2025 Guillaume Grzych, R. Diesnis, Thierry Dupré et al.

Nitrous oxide (N2O) was originally used for medical and industrial purposes, but its recreational use has dramatically increased, raising a major global public health concern. Chronic inhalation is associated with neurological, metabolic, and psychiatric complications, as well as addiction. To address these challenges, the PROTOSIDE network was developed to provide a multidisciplinary approach...

Three-day delta-9-tetrahydrocannabinol (THC) exposure eliminates long-term depression in ventral tegmental area of young, but not adult mice.

Journal of Cannabis Research May 31, 2025 Michael Von Gunten, Seth Hoffman, Addison Smartt et al.

Ventral tegmental area (VTA) dopamine signaling plays a key role in reward learning and drug dependence. VTA dopamine cell activity is regulated in part by local GABA interneurons, which participate in regulating reward prediction. Previously, our lab identified a cannabinoid type 1 receptor (CB1)-dependent form of excitatory long-term depression (LTD) in VTA GABA cells. LTD was eliminated in...